Abstract
The prevalence and severity of allergic asthma continue to rise, lending urgency to the search for environmental triggers and genetic substrates. Using microarray analysis of pulmonary gene expression and single nucleotide polymorphism–based genotyping, combined with quantitative trait locus analysis, we identified the gene encoding complement factor 5 (C5) as a susceptibility locus for allergen-induced airway hyperresponsiveness in a murine model of asthma. A deletion in the coding sequence of C5 leads to C5-deficiency and susceptibility. Interleukin 12 (IL-12) is able to prevent or reverse experimental allergic asthma. Blockade of the C5a receptor rendered human monocytes unable to produce IL-12, mimicking blunted IL-12 production by macrophages from C5-deficient mice and providing a mechanism for the regulation of susceptibility to asthma by C5. The role of complement in modulating susceptibility to asthma highlights the importance of immunoregulatory events at the interface of innate and adaptive immunity in disease pathogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Evans, R. D. et al. National trends in the morbidity and mortality of asthma in the US. Prevalence, hospitalization and death from asthma over two decades: 1965–1984. Chest 91, 65S– 74S (1987).
Wills-Karp, M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17, 255–281 (1999).
Daniels, S. E. et al. A genome-wide search for quantitative trait loci underlying asthma. Nature 383, 247– 250 (1996).
A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The Collaborative Study on the Genetics of Asthma (CSGA). Nature Genet. 15, 389– 392 (1997).
Ober, C. et al. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum. Mol. Genet. 7, 1393–1398 (1998).
Wjst, M. et al. A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics 58, 1–8 (1999).
Wills-Karp, M. et al. Interleukin-13: central mediator of allergic asthma. Science 282, 2258–2261 ( 1998).
Gavett, S.H. et al. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182, 1527–1536 ( 1995).
Keane-Myers, A., Wysocka, M., Trinchieri, G. & Wills-Karp, M. Resistance to antigen-induced airway hyperresponsiveness requires endogenous production of IL-12. J. Immunol. 161, 919 –926 (1998).
Ewart, S. E. et al. Identification of quantitative trait loci controlling allergen-induced airway hyperresponsiveness in inbred mice. Am. J. Resp. Cell. Molec. Biol.
Wetsel, R. A., Fleischer, D. T. & Haviland, D. L. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5′-exon. J. Biol. Chem. 265, 2435–2440 ( 1990).
Polorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085–2088 (1998).
Vogel, S. N. et al. Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an lpsn gene: In vivo evidence for a dominant negative mutation. J. Immunol. 162, 5666–5670 (1999).
Johnson, E. & Hetland, G. Mononuclear phagocytes have the potential to synthesize the complete functional complement system. Scand. J. Immunol. 27, 489–493 (1988).
Hindmarsh, E. J. & Marks, R. M. Complement activation occurs on subendothelial extracellular matrix in vitro and is initiated by retraction or removal of overlying endothelial cells. J. Immunol. 160, 6128–6136 ( 1998).
Wozencraft, A. O., Sayers, G. & Blackwell, J. M. Macrophage type 3 complement receptors mediate serum-independent binding of Leishmania donovani. Detection of macrophage-derived complement on the parasite surface by immunoelectron microscopy. J. Exp. Med. 164, 1332–1337 ( 1986).
Bergh, K. & Iversen, O. J. Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich-ELISA for the quantification of C5a des Arg in plasma. J. Immunol. Methods 152, 79–87 (1992).
Heller, T. et al. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury. J. Immunol. 163, 985– 994 (1999).
Hong, K., Kinoshita, T., Miyazaki, W., Izawa, T. & Inoue, K. An anticomplementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade . J. Immunol. 122, 2418– 2423 (1979).
Wittmann, M. et al. C5a suppresses the production of IL-12 by IFN-γ -primed and lipopolysaccharide-challenged human monocytes. J. Immunol. 162, 6763–6769 ( 1999).
Braun, M. C., Lahey, E. & Kelsall, B. L. Selective suppression of IL-12 production by chemoattractants . J. Immunol. 164, 3009– 3017 (2000).
Gerard, C. & Gerard, N. P. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12, 775–808 (1994).
Loots, G. G. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 288,136– 140 (2000).
Fearon, D. T. The complement system and adaptive immunity. Semin. Immunol. 10, 355–361 (1998).
Mosser, D. M. & Karp, C. L. Receptor mediated subversion of macrophage cytokine production by intracellular pathogens. Curr. Opin. Immunol. 11, 406–411 (1999).
Wang, C. et al. Hemolytically inactive C5b67 complex: an agonist of polymorphonuclear leukocytes. Blood 85, 2570– 2578 (1995).
Wang, C., Gerard, N.P. & Nicholson-Weller, A. Signaling by hemolytically inactive C5b67, an agonist of polymorphonuclear leukocytes. J. Immunol. 156, 786–792 (1996).
Kilgore, K. S. et al. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-κ B activation. Am. J. Pathol. 150, 2019–2031 (1997).
Morgan, E. L. et al. Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis. J. Immunol. 148, 3937–3942 (1992).
Schindler, R., Gelfand, J. A. & Dinarello, C. A. Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. Blood 76, 1631–1638 (1990).
Cavaillon, J.M., Fitting, C., Haeffner-Cavaillon, N. Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages . Eur. J. Immunol. 20, 253– 257 (1990).
Sam, H. & Stevenson, M. M. Early IL-12 p70, but not p40, production by splenic macrophages correlates with host resistance to blood-stage Plasmodium chabaudi AS malaria. Clin. Exp. Immunol. 117, 343–349 (1999).
Wang, Y., Rollins, S. A., Madri, J. A. & Matis, L. A. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc. Natl Acad. Sci. USA 92, 8955–8959 (1995).
Tsuji, R. F. et al. Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon γ: a possible initiating role of B cells. J. Exp. Med. 186, 1015–1026 ( 1997).
Gervais, F., Stevenson, M. & Skamene, E. Genetic control of resistance to Listeria monocytogenes: regulation of leukocyte inflammatory responses by the Hc locus. J. Immunol. 132, 2078–2083 (1984).
Barton, P. A. & Warren, J. S. Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock. Infect. Immun. 61, 1474–1481 (1993).
Trinchieri, G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70, 83–243 (1998).
Hopken, U. E., Lu, B., Gerard, N. P. & Gerard, C. Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J. Exp. Med. 186, 749– 756 (1997).
van der Pouw Kraan, T. C. et al. Reduced production of IL-12 and IL-12-dependent IFN-γ release in patients with allergic asthma. J. Immunol. 158, 5560–5565 (1997).
Naseer, T. et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am. J. Respir. Crit. Care Med. 155, 845–851 ( 1997).
Germer, S., Holland, M. J. & Higuchi, R. High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res 10, 258–266 (2000).
Karp, C. L. et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273, 228– 231 (1996).
Acknowledgements
Supported in part by NIH grants AI40507, DE12167 (C.L.K.); ES09606, HL58527 (M.W.-K.); and RR00097 (S.L.E.). BMBF grant 01VM9305 (J.K.); a Michigan State University All-University Research Initiation Grant (S.L.E.); and EPA grant R826724 (M.W.-K.). The authors thank M. Shin for the gift of K-76.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karp, C., Grupe, A., Schadt, E. et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immunol 1, 221–226 (2000). https://doi.org/10.1038/79759
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/79759
This article is cited by
-
Strategies for eQTL mapping in allopolyploid organisms
Theoretical and Applied Genetics (2020)
-
Revealing the acute asthma ignorome: characterization and validation of uninvestigated gene networks
Scientific Reports (2016)
-
C5a receptor signalling in dendritic cells controls the development of maladaptive Th2 and Th17 immunity in experimental allergic asthma
Mucosal Immunology (2013)
-
The arthritis severity locus Cia5a regulates the expression of inflammatory mediators including Syk pathway genes and proteases in pristane-induced arthritis
BMC Genomics (2012)